Search research articles
Contact Us
Filters
Showing results (661-670 of 674) with videos related to
Page
of 68
Sort By:
JCI Insight
|
November 25, 2025
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 8, 2025
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
British Journal of Cancer
|
August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancer
A Prat, A Lluch, J Albanell, et al.
Nature Medicine
|
February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
Benjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
Resuscitation
|
December 14, 2023
Reporting standard for describing first responder systems, smartphone alerting systems, and AED networks
M P Müller, C Metelmann, K C Thies, et al.
International Journal of Emergency Medicine
|
May 8, 2026
Barriers and facilitators while implementing community first responder systems in a western setting: mixed-methods expert consensus
E Moens, E Degraeuwe, M L Caputo, et al.
Nature Genetics
|
January 8, 2021
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer
Arafath K Najumudeen, Fatih Ceteci, Sigrid K Fey, et al.
Nature
|
November 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance
Mark White, Megan L Mills, Laura M Millett, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
|
March 14, 2026
Barriers and enablers to public access defibrillation - an international RAND-UCLA consensus study
K C Thies, C Metelmann, B Metelmann, et al.
Gut
|
April 28, 2022
CXCR2 inhibition enables NASH-HCC immunotherapy
Jack Leslie, John B G Mackey, Thomas Jamieson, et al.
Page
of 68
Search research articles
Search
Showing results (661-670 of 674) with videos related to
Sort By:
Page
of 68
JCI Insight
|
November 25, 2025
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 8, 2025
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
British Journal of Cancer
|
August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancer
A Prat, A Lluch, J Albanell, et al.
Nature Medicine
|
February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
Benjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
Resuscitation
|
December 14, 2023
Reporting standard for describing first responder systems, smartphone alerting systems, and AED networks
M P Müller, C Metelmann, K C Thies, et al.
International Journal of Emergency Medicine
|
May 8, 2026
Barriers and facilitators while implementing community first responder systems in a western setting: mixed-methods expert consensus
E Moens, E Degraeuwe, M L Caputo, et al.
Nature Genetics
|
January 8, 2021
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer
Arafath K Najumudeen, Fatih Ceteci, Sigrid K Fey, et al.
Nature
|
November 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance
Mark White, Megan L Mills, Laura M Millett, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
|
March 14, 2026
Barriers and enablers to public access defibrillation - an international RAND-UCLA consensus study
K C Thies, C Metelmann, B Metelmann, et al.
Gut
|
April 28, 2022
CXCR2 inhibition enables NASH-HCC immunotherapy
Jack Leslie, John B G Mackey, Thomas Jamieson, et al.
Page
of 68